KR19990080214A - Functional drink containing health extract of citrus peel - Google Patents

Functional drink containing health extract of citrus peel Download PDF

Info

Publication number
KR19990080214A
KR19990080214A KR1019980013283A KR19980013283A KR19990080214A KR 19990080214 A KR19990080214 A KR 19990080214A KR 1019980013283 A KR1019980013283 A KR 1019980013283A KR 19980013283 A KR19980013283 A KR 19980013283A KR 19990080214 A KR19990080214 A KR 19990080214A
Authority
KR
South Korea
Prior art keywords
extract
citrus
citrus peel
hesperidin
functional
Prior art date
Application number
KR1019980013283A
Other languages
Korean (ko)
Inventor
복성해
정태숙
배기환
박용복
최명숙
권용국
현병화
최양규
이철호
문석식
Original Assignee
박호군
한국과학기술연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박호군, 한국과학기술연구원 filed Critical 박호군
Priority to KR1019980013283A priority Critical patent/KR19990080214A/en
Priority to JP2000517728A priority patent/JP3333777B2/en
Priority to DE69817862T priority patent/DE69817862T2/en
Priority to EP98951777A priority patent/EP1063988A1/en
Priority to EP98951775A priority patent/EP1024819A1/en
Priority to EP98951776A priority patent/EP1032381B1/en
Priority to CN98810715A priority patent/CN1278182A/en
Priority to CN98810701A priority patent/CN1124133C/en
Priority to PCT/KR1998/000324 priority patent/WO1999021549A1/en
Priority to CA002307890A priority patent/CA2307890A1/en
Priority to CA002307891A priority patent/CA2307891A1/en
Priority to PCT/KR1998/000322 priority patent/WO1999021570A1/en
Priority to CN98810708A priority patent/CN1124134C/en
Priority to JP2000517706A priority patent/JP2001520992A/en
Priority to CA002307553A priority patent/CA2307553C/en
Priority to PCT/KR1998/000323 priority patent/WO1999021548A1/en
Priority to JP2000517707A priority patent/JP2001520993A/en
Priority to US09/181,393 priority patent/US6165984A/en
Publication of KR19990080214A publication Critical patent/KR19990080214A/en
Priority to US09/751,101 priority patent/US20010002264A1/en
Priority to US09/728,917 priority patent/US20010014357A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 감귤류의 과피 추출물을 이용하여 제조된 건강개선용 기능성 음료에 관한 것으로, 보다 상세하게는 감귤류 과피 추출물 또는 감귤류 과피 유래의 바이오플라보노이드(bioflavonoids)를 이용하여 제조된 건강개선용 기능성 음료에 관한 것이다.The present invention relates to a functional beverage for health improvement manufactured using the extract of citrus fruit, and more particularly, to a functional beverage for health improvement manufactured using bioflavonoids derived from citrus fruit extract or citrus peel. will be.

Description

감귤류의 과피 추출물을 포함하는 건강개선용 기능성 음료Functional drink containing health extract of citrus peel

본 발명은 감귤류의 과피 추출물을 이용하여 제조된 건강개선용 기능성 음료에 관한 것으로, 보다 상세하게는 감귤류 과피 추출물 또는 감귤류 과피 유래의 바이오플라보노이드를 이용하여 제조된 건강개선용 기능성 음료에 관한 것이다.The present invention relates to a functional beverage for health improvement manufactured using the extract of citrus fruit, and more particularly, to a functional beverage for health improvement manufactured using bioflavonoids derived from citrus fruit extract or citrus peel.

감귤류의 과피에는 각종 비타민, 소량의 리모노이드, 약 0.01 %의 페놀릭(phenolic), 약 1 내지 7%의 바이오플라보노이드가 존재한다(Ranganna S. et al.,Citrus fruits: varieties, chemistry, technology, and quality evaluation. Part Ⅱ. CRC Crit. Rev. Food Sci. Nutri. Boca Raton,18, 313-386, CRC Press(1983)). 이 중 바이오플라보노이드에는 하기 표 1과 같이 매우 다양한 플라보노이드가 포함되어 있다(Horowitz, R. M. et al.,J. org. Chem.,25, 2183-2187 (1960)).Citrus peels contain various vitamins, small amounts of limonoids, about 0.01% phenolic and about 1 to 7% bioflavonoids (Ranganna S. et al., Citrus fruits: varieties, chemistry, technology, and quality evaluation.Part II.CRC Crit. Rev. Food Sci.Nutri.Boca Raton , 18 , 313-386, CRC Press (1983)). Among them, bioflavonoids include a wide variety of flavonoids as shown in Table 1 (Horowitz, RM et al., J. org. Chem. , 25 , 2183-2187 (1960)).

표 1에서 보듯이 헤스페리딘류는 오렌지, 레몬, 탄제린의 과피 추출물에 많고 나린진은 자몽의 과피 추출물에 많이 존재한다.As shown in Table 1, hesperidin is found in the extract of orange, lemon, and tangerine, and naringin is present in the extract of grapefruit.

감귤류 과피는 각종 약리활성, 예를 들어, 혈압, 동맥경화증 등 심장순환기 질환 예방효과, 항염증작용, 항산화작용, 항암작용, 항바이러스작용, 모세혈관 강화작용 등을 갖는 것으로 알려져 있다. 예들 들어, 헤스페리딘 또는 헤스페레틴은 모세혈관 강화, 투과성(Permeability) 감소, 혈압 강하, 혈중 콜레스테롤 강하, 항혈소판 응집(Antiplatelet aggregation), 항염증 및 항바이러스 작용을 한다고 알려져 있고(Meyer, O. C.,Angiology, 45, 579-584(1994); Struckmann J. R., et al.,Angiol., 45, 419-428(1994); Matsubara, Y., et al.,Japan Organic Synthesis Chem. Association Journal., 52, 318-327(1994. Mar.); Galati E. M., et al.,Farmaco., 51(3), 219-221(1996, Mar.); Monforte MT., et al.,Farmaco., 50(9), 595-599(1995, Sep.); JP 95-86929; JP 95-86930; Chung, M. I., et al.,Chin. Pharm. J.(Taipei)., 46, 429-437(1994, Nov.); Galati, E. M., et al.,Farmaco., 40(11), 709-712(1994, Nov.); and Emim J. A., et al.,J. Pharm. Pharmacol., 46(2),118-122(1994)), 바이오플라보노이드는 항산화, 혈압강하, 항암 및 항바이러스 작용을 한다고 알려져 있으며(Saija, A., et al.,Free Radical Biol. Med., 19, 481-486(1995); Matsubara, Y., et al., 상기 문헌; Galati E. M., et al., 상기 문헌; Felicia V., et al.,Nutr. Cancer, 26, 167-181(1996); EP 0352147 A2(1990.1.24); and Kaul, T. N., et al.,J. Med. Virol., 15,71-79(1985)), 나린제닌 및 나린진은 콜레스테롤 강하, 항암 및 항위궤양(알콜로부터 보호) 작용을 한다고 알려져 있다(Monforte MT. et al., 상기 문헌; JP 95-86929; JP 95-86930; Felicia V. et al., 상기 문헌; EP 0352147 A2(1990.1.24); and Martin M. J. et al.,Pharmacol., 49,144-150(1994)).Citrus peels are known to have a variety of pharmacological activities, for example, blood pressure, arteriosclerosis, cardiovascular disease prevention, anti-inflammatory, antioxidant, anticancer, antiviral, capillary potentiation. For example, hesperidin or hesperetine is known to have capillary fortification, reduced permeability, lowered blood pressure, lowered blood cholesterol, antiplatelet aggregation, anti-inflammatory and antiviral effects (Meyer, OC, Angiology). , 45 , 579-584 (1994); Struckmann JR, et al., Angiol., 45 , 419-428 (1994); Matsubara, Y., et al., Japan Organic Synthesis Chem. Association Journal., 52 , 318 -327 (1994. Mar.); Galati EM, et al., Farmaco., 51 (3) , 219-221 (1996, Mar.); Monforte MT., Et al., Farmaco., 50 (9) , 595-599 (1995, Sep.); JP 95-86929; JP 95-86930; Chung, MI, et al., Chin. Pharm. J. (Taipei) ., 46 , 429-437 (1994, Nov.) Galati, EM, et al., Farmaco., 40 (11) , 709-712 (1994, Nov.); and Emim JA, et al., J. Pharm.Pharmacol ., 46 (2), 118-122 (1994)), bioflavonoids are known to have antioxidant, hypotensive, anticancer and antiviral effects (Saija, A., et al., Free Radical Biol. Med., 19 , 481-486 (1995); Mats ubara, Y., et al., supra; Galati EM, et al., supra; Felicia V., et al., Nutr. Cancer, 26 , 167-181 (1996); EP 0352147 A2 (1990.1.24) and Kaul, TN, et al., J. Med. Virol., 15, 71-79 (1985)), naringenin and naringin are known to have cholesterol lowering, anticancer and anti-gastric ulcer (protection from alcohol) actions. (Monforte MT. et al., supra; JP 95-86929; JP 95-86930; Felicia V. et al., Supra; EP 0352147 A2 (1990.1.24); and Martin MJ et al., Pharmacol., 49, 144-150 (1994)).

또한, 감귤의 과피와 씨에는 리모노이드계 물질이 존재하는데 이들이 항암활성을 갖고 있다는 사실도 밝혀져 있다(Lam, L.K.T. et al.,Inhibition of chemically induced carcinogenesis by citrus limonoids. In Food Phytochemicals for Cancer Prevention, Vol. I,ACS Symposium series No. 546, Huang, M. T., O. Osawa, C. T. Ho, R. Rosen(ed). 1993).In addition, citrus rinds and seeds contain limonoids, which have been shown to have anticancer activity (Lam, LKT et al., Inhibition of chemically induced carcinogenesis by citrus limonoids.In Food Phytochemicals for Cancer Prevention, Vol. I, ACS Symposium series No. 546, Huang, MT, O. Osawa, CT Ho, R. Rosen (ed). 1993).

감귤에 포함된 페놀릭이 항암효과를 갖는다는 보고도 많다(Stich H. F. et al.,Adv. Exp. Med.,177, 1-29 (1984); Stavric B. et al.,Effects of flavonoids on mutagenicity and bioavailability of xenobiotics in foods.in Huang M. T., C. T. Ho, C. Y. Lee(eds) (1992):Phenolic compounds in food and their effects on health. Ⅱ. Antioxidants and cancer prevention.ACS Symposium Series 507, Washington, D. C., A. C. S. pp239-249). 또한 페놀릭, 특히 엘라긴산, 레루린산, 카페인산의 폐암억제효과(Castonguay A.Ann. N. Y. Acad. Sci.,686, 177-185 (1993)), 및 쥐의 혀에 발생하는 암의 억제 효과(Tanaka T. et al.,Carcinogenesis,14, 1321-1325 (1993))도 보고된 바 있다.There are many reports that phenolic in citrus fruits has anticancer effect (Stich HF et al., Adv. Exp. Med. , 177 , 1-29 (1984); Stavric B. et al., Effects of flavonoids on mutagenicity and bioavailability of xenobiotics in foods.in Huang MT, CT Ho, CY Lee (eds) (1992): Phenolic compounds in food and their effects on health.II.Antioxidants and cancer prevention.ACS Symposium Series 507, Washington, DC, ACS pp239-249). In addition, phenolic, especially Ella ginsan, toy acid, caffeic acid in the cancer suppressing effect (Castonguay A. Ann. NY Acad. Sci., 686, 177-185 (1993)), and inhibition of cancer generated in the tongue of mice effect (Tanaka T. et al., Carcinogenesis , 14 , 1321-1325 (1993)) has also been reported.

본 발명자들은 이미 감귤류 과피 추출물, 헤스페리딘 또는 나린진이 콜레스테롤 생합성에 관여하는 효소인 3-하이드록시-3-메틸글루타릴 코에이(HMG CoA) 환원효소를 저해하며, 콜레스테롤 흡수에 관여하는 효소인 아세틸 코에이:콜레스테롤 아실트랜스퍼레이즈(Acyl CoA : cholesterol acyltransferase(ACAT))를 저해한다는 사실을 확인하여 각각 한국특허출원 제 97-55578, 97-55579, 97-55580 호로 출원한 바 있으며, 이러한 결과를 종합할 때 감귤류 과피 추출물, 헤스페리딘 또는 나린진을 각종 야채쥬스, 과일쥬스, 탄산음료, 기타 음료 등에 첨가하여 지질대사를 개선할 수 있다는 점에 착안하여 본 발명을 완성하게 되었다.The inventors have already discovered that citrus peel extract, hesperidin or naringin inhibit 3-hydroxy-3-methylglutaryl coeigen (HMG CoA) reductase, an enzyme involved in cholesterol biosynthesis, and acetyl, an enzyme involved in cholesterol absorption. It confirmed that it inhibits the Coyl: cholesterol acyltransferase (ACAT) and filed with Korean Patent Application Nos. 97-55578, 97-55579, 97-55580, respectively. When the citrus peel extract, hesperidin or naringin can be added to various vegetable juices, fruit juices, carbonated drinks, other beverages, the present invention was completed.

본 발명의 목적은 감귤류 과피 추출물, 또는 그로부터 유래된 바이오플라보노이드를 포함하는 건강개선용 기능성 음료를 제공하는 것이다.It is an object of the present invention to provide a functional beverage for health improvement comprising a citrus peel extract, or a bioflavonoid derived therefrom.

본 발명에서는 감귤류 과피 추출물, 또는 이로부터 분리되거나 시판되는 헤스페리딘 또는 나린진을 각각 포함하는 건강개선용 기능성 음료로서, 야채쥬스, 과일쥬스 및 탄산음료를 제공한다.In the present invention, a citrus fruit extract, or a health-improving functional beverage containing hesperidin or naringin, which are separated or commercially available from the same, provides vegetable juice, fruit juice and carbonated beverage.

본 발명에서 감귤류란 하귤, 당유자, 오렌지, 레몬, 감귤, 자몽 또는 유자 등을 말한다. 본 발명에 사용한 감귤류 과피를 얻기 위해서는 우선, 농약 처리를 하지 않고 감귤류를 생산하거나 인체에 무해한 저공해 농약, 또는 생물학적 방제제를 이용하여 감귤류를 생산해야 한다.Citrus fruits in the present invention refers to a mandarin orange, sugar citron, orange, lemon, citrus, grapefruit or citron. In order to obtain citrus peels used in the present invention, citrus fruits must first be produced without pesticide treatment or by using low pollution pesticides or biological control agents that are harmless to humans.

본 발명에서는 감귤류 과피 추출물을 제조하기 위하여 다음과 같은 방법들을 사용한다. 즉, 감귤류의 과피를 건조한 후, 건조 과피 1 kg당 20 내지 95 % 에탄올 3 내지 30ℓ를 가하고, 25 내지 80℃에서 1 내지 12 시간 동안 추출한 후, 이 추출물을 여과한 다음, 여액을 진공농축함으로써 추출물을 얻을 수 있다.In the present invention, the following methods are used to prepare the citrus peel extract. That is, after drying the citrus peel, 3 to 30 l of 20 to 95% ethanol per kg of dried peel was added, extracted at 25 to 80 ° C. for 1 to 12 hours, and then the extract was filtered and the filtrate was concentrated in vacuo. Extracts can be obtained.

다른 한편으로는, 감귤류의 과피를 건조한 후, 건조 과피 1 kg당 0.1 내지 2 % Ca(OH)2또는 NaOH 5 내지 30ℓ를 가하고, 25 내지 60℃에서 1 내지 5 시간 동안 추출한 후, 이 추출물을 여과한 다음, 여액에 1N HCl 용액을 가하여 혼합액의 pH를 4.0 내지 7.0으로 조절하고, 냉장실에서 10 내지 48 시간 방치하여 생성된 침전물을 회수한 후 건조하는 방법에 의해 추출물을 제조할 수도 있다.On the other hand, after drying the citrus peel, 0.1 to 2% Ca (OH) 2 or 5 to 30 L of NaOH per 1 kg of dried peel is added and extracted at 25 to 60 ° C. for 1 to 5 hours, and then the extract is extracted. After filtering, 1N HCl solution was added to the filtrate to adjust the pH of the mixed solution to 4.0 to 7.0, and the resultant precipitate was recovered by drying in a refrigerating chamber for 10 to 48 hours, followed by drying.

본 발명의 기능성 식품인 야채쥬스, 과일쥬스 및 탄산음료는 음료 1000ml에 대하여 헤스페리딘 200 내지 10000mg, 나린진 200 내지 10000mg 또는 감귤류 과피 추출물 10 내지 100g을 포함한다.The functional foods of vegetable juice, fruit juice and carbonated beverages of the present invention include 200-10000 mg of hesperidin, 200-10000 mg of naringin or 10-100 g of citrus rind extract with respect to 1000 ml of beverage.

상기 야채쥬스로는 당근쥬스를 예로 들 수 있으며, 상기 과일쥬스로는 포도쥬스, 파인애플쥬스, 사과쥬스 또는 바나나쥬스를 예로 들 수 있고, 상기 탄산음료로는 코카콜라 및 펩시콜라를 예로 들 수 있다.The vegetable juice may include carrot juice, and the fruit juice may include grape juice, pineapple juice, apple juice or banana juice, and the carbonated beverage may include coca cola and pepsi.

본 발명의 방법에 의해 제조된, 감귤류 과피 추출물을 포함하는 건강개선용 음료 조성물을 섭취할 경우, 심장 순환기계 질환, 암, 바이러스, 염증, 당뇨 등에 대한 우리 몸의 방어능력 항상에 크게 도움이 될 것이다.Ingesting a beverage composition for improving health, comprising the extract of citrus peel, prepared by the method of the present invention, will greatly help our body's defense ability against cardiovascular disease, cancer, virus, inflammation, diabetes, etc. will be.

이하 본 발명을 다음과 같은 실시예에 의하여 더욱 상세하게 설명하고자 한다. 단, 다음의 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위가 이것들 만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following Examples are only for illustrating the present invention, and the scope of the present invention is not limited to these.

실시예 1: 감귤류 과피 추출물으로부터 바이오플라보노이드의 추출 및 정량 방법Example 1 Extraction and Quantitative Methods of Bioflavonoids from Citrus Peel Extracts

한국 제주도에서 생산된 하귤, 당유자, 감귤(tangerine), 전남에서 생산된 유자 및 수입품인 오렌지, 자몽 및 레몬의 껍질을 실온에서 건조한 후 입경 100㎛-200㎛의 크기로 분말화하였다. 이 분말을 500 ㎎씩 정밀하게 달아 메탄올 50 ㎖ 씩을 가하여 50℃에서 6시간 동안 수욕 추출한 다음 냉각 후 여과하고 다시 메탄올을 가하여 50㎖로 만든 용액을 검액으로 하였다. 필요한 경우에는 검량선의 작성에 사용한 범위내의 농도가 되도록 희석하여 사용하였다.The peels of oranges, grapefruits and lemons, which were produced in Jeju, South Korea, were imported from citrus fruits, tangerines, citrons and imported citrus fruits from Jeonnam, and then powdered to a particle size of 100 μm-200 μm. 500 mg of this powder was precisely weighed, and 50 ml of methanol was added thereto, followed by extraction with a water bath at 50 ° C. for 6 hours, followed by cooling, filtration, and addition of methanol to make a 50 ml solution. If necessary, the mixture was diluted to have a concentration within the range used for preparing the calibration curve.

상기와 같이 얻어진 과피 추출물의 성분을 조사하기 위하여 다음과 같은 조건으로 HPLC 분석을 실시하였다. 상기 검액 5.0 μl를 37% 메탄올로 미리 평형화된 리크로소브(Lichrosorb) RP-8 컬럼(5 μm, 4 x 250 mm)이 장착된 HPLC에 주입하였다. 이 때 칼럼의 온도는 30℃로 조절하고, 37% 메탄올을 이동상으로 사용하여 1.0 ml/분의 유속으로 용출시켰다. 따로, 헤스페리딘과 나린진(Sigma Co.) 표준품을 메탄올에 용해시켜 최종 농도가 각각 0.1, 0.2, 0.3, 0.4 및 0.5 mg/ml 가 되도록 표준용액을 조제하여 동일한 조건에서 HPLC를 실시하였다. 용출물을 UV-VIS 분광광도계(spectrophotometer)를 사용하여 280 nm에서 검출하고, 검량선과 과피추출물의 HPLC 프로필(profile)의 면적을 비교 분석하여 함량을 계산한 결과, 과피추출 농축액중 헤스페리딘 및 나린진의 함량은 다음과 같았다.In order to investigate the components of the skin extract obtained as described above, HPLC analysis was performed under the following conditions. 5.0 μl of the sample solution was injected into an HPLC equipped with a Lichrosorb RP-8 column (5 μm, 4 × 250 mm) previously equilibrated with 37% methanol. The temperature of the column was adjusted to 30 ° C. and eluted at a flow rate of 1.0 ml / min using 37% methanol as the mobile phase. Separately, hesperidin and nargine (Sigma Co.) standards were dissolved in methanol and standard solutions were prepared so that the final concentrations were 0.1, 0.2, 0.3, 0.4 and 0.5 mg / ml, respectively, and HPLC was performed under the same conditions. The eluate was detected at 280 nm using a UV-VIS spectrophotometer, and the content was calculated by comparing the area of the HPLC profile of the extract with the calibration curve and the content of hesperidin and naringin in the extract extracted from the extract. The content was as follows.

각종 감귤류 과피중 헤스페리딘 및 나린진의 함량(%)Content of Hesperidin and Naringin in Various Citrus Peels 감귤류 종류Citrus varieties 헤스페리딘Hesperidin 나린진Narinjin 하 귤당 유 자오렌지(orange)레몬(lemon)감귤(tangerine)자몽(grape fruit)유 자Orange Tangerine Orange Lemon Lemon Tangerine Grapefruit -0.402.101.402.10-0.80-0.402.101.402.10-0.80 3.403.90미량미량미량4.700.803.403.90 Micro Trace Micro Trace 4.700.80

실시예 2: 감귤 과피 추출물의 제조Example 2: Preparation of Citrus Peel Extract

(1) 에탄올을 이용한 방법(1) Method using ethanol

제주도산 감귤 과피를 건조한 후 건조 감귤류 과피 500 g에 30% 에탄올 용액 5ℓ를 가하고 60℃에서 5시간 동안 추출하였다. 이 추출물을 면직물(cotton cloth)을 이용하여 여과한 다음 여액을 진공농축하여 190 g의 시럽상의 추출물을 얻었다. 상기 실시예 1에서와 같은 방법으로 추출물중 헤스페리딘의 함량을 측정한 결과, 이 추출물 190 g 속에는 헤스페리딘 5.1 g이 들어 있었다. HPLC를 이용하여 추출물의 성분을 분석한 결과, 수분 65%, 당분 28%(과당 11%, 포도당 11%, 슈크로즈 6%), 헤스페리딘 2.7% 및 기타 회분 등의 미량성분으로 구성되어 있었다.After drying the citrus peel from Jeju Island, 5 l of 30% ethanol solution was added to 500 g of dried citrus peel and extracted at 60 ° C. for 5 hours. The extract was filtered using cotton cloth, and the filtrate was concentrated in vacuo to obtain 190 g of syrupy extract. As a result of measuring the content of hesperidin in the extract in the same manner as in Example 1, 190 g of hesperidin was contained in the extract. As a result of analyzing the components of the extract using HPLC, it consisted of trace components such as water 65%, sugar 28% (11% fructose, glucose 11%, sucrose 6%), hesperidin 2.7% and other ash.

(2) Ca(OH)2를 이용한 방법(2) Method using Ca (OH) 2

제주도산 감귤 과피를 건조한 후, 건조된 감귤류 과피 500 g에 0.5% Ca(OH)2용액 5ℓ를 가하고 상온에서 저어주면서 1시간 동안 추출하였다. 이 추출물을 면직물로 여과한 후 여액에 1N HCl 용액을 가하여 혼합액의 pH가 4.0∼4.5, 또는 6.80∼7.0이 되게 한 후 5℃ 냉장실에서 24시간 방치하였다. 이때 생성된 침전물을 회수한 후 건조하여 각각 5 g 및 10 g의 건조된 분말을 얻었다. 침전된 분말을 실시예 1에서와 같이 HPLC로 정량분석한 결과 헤스페리딘이 각각 3.2 g 및 6.55 g 포함되어 있어, 헤스페리딘의 순도는 각각 64% 및 65%였다.After drying the citrus peel from Jeju Island, 5 liters of 0.5% Ca (OH) 2 solution was added to 500 g of the dried citrus peel and stirred for 1 hour while stirring at room temperature. The extract was filtered with cotton fabric and 1N HCl solution was added to the filtrate to make the pH of the mixed solution 4.0 to 4.5, or 6.80 to 7.0, and then left in a 5 ° C. cold room for 24 hours. At this time, the resulting precipitate was recovered and dried to obtain 5 g and 10 g of dried powder, respectively. The precipitated powder was quantitatively analyzed by HPLC as in Example 1, containing 3.2 g and 6.55 g of hesperidin, respectively, and the purity of hesperidin was 64% and 65%, respectively.

(3) NaOH를 이용한 방법(3) Method using NaOH

제주도산 감귤 과피를 건조한 후, 건조된 감귤류 과피 500 g에 0.5% NaOH 5ℓ를 가하고 상온에서 저으면서 1시간 동안 추출한 다음 면직물로 여과하였다. 여액에 1 N HCl 용액을 첨가하여 혼합액의 pH가 4.0∼4.5 또는 6.8∼7.0이 되게 한 후 5℃ 냉장실에서 24시간 방치하였다. 이때 생성된 침전물을 회수한 후 건조하여 각각 44 g 및 49 g의 건조분말을 얻었다. 건조 분말로부터 HPLC에 의해 각각 13.6 g, 9.8 g의 헤스페리딘을 회수하였다(순도: 각각 31%, 20%).After drying the citrus peel from Jeju Island, 5 l of 0.5% NaOH was added to 500 g of the dried citrus peel and stirred at room temperature for 1 hour, followed by filtration with cotton fabric. 1N HCl solution was added to the filtrate to bring the pH of the mixed solution to 4.0-4.5 or 6.8-7.0, and then left in a 5 ° C. refrigerator for 24 hours. At this time, the resulting precipitate was recovered and dried to obtain 44 g and 49 g of dry powder, respectively. 13.6 g and 9.8 g of hesperidin, respectively, were recovered from the dry powder by HPLC (purity: 31%, 20%, respectively).

실시예 3: 감귤 과피 추출물의 경구독성실험Example 3: Oral Toxicity Test of Citrus Peel Extract

7-8 주령의 특정 병원체 부재(specific pathogens free) ICR 마우스로서 체중 25-29 g의 암컷 6마리와 체중 34-38 g의 숫컷 6 마리를 온도 22±1℃, 습도 55±5%, 조명 12L/12D의 동물실내에서 사육하였다. 마우스는 실험에 사용되기 전 1주일 정도 순화시켰다. 실험동물용 사료((주)제일제당, 마우스 및 랫드용) 및 음수는 멸균한 후 공급하였으며 자유섭취시켰다.Specific pathogens free of 7-8 weeks of age, 6 females weighing 25-29 g and 6 males weighing 34-38 g, temperature 22 ± 1 ° C, humidity 55 ± 5%, illumination 12L It was bred in the animal room of / 12D. Mice were allowed to acclimate for about a week before being used in the experiment. Feed for experimental animals (Jeil Jedang Co., Ltd., mice and rats) and drinking water were supplied after sterilization and free ingestion.

실시예 2의 (1)에서 얻은 감귤류 과피 추출물을 0.5% 트윈 80을 용매로 하여 100 mg/ml 농도로 조제한 후, 마우스 체중 20g 당 0.2 ml씩 경구투여하였다. 시료는 1회 경구 투여하였으며 투여 후 10일 동안 다음과 같이 부작용 또는 치사 여부를 관찰하였다. 즉, 투여당일은 투여 후 1시간, 4시간, 8시간, 12시간 뒤에 그리고 투여 익일부터 10일째까지는 매일 오전, 오후 1회 이상씩 일반증상의 변화 및 사망동물의 유무를 관찰하였다. 또한, 투여 10일째에 동물을 치사시켜 해부한 후 육안으로 내부 장기를 검사하였다. 투여당일부터 1일 간격으로 체중의 변화를 측정하여 감귤 과피 추출물에 의한 동물의 체중 감소 현상을 관찰하였다.Citrus peel extract obtained in (1) of Example 2 was prepared at a concentration of 100 mg / ml using 0.5% Tween 80 as a solvent, followed by oral administration of 0.2 ml per 20 g of mouse body weight. Samples were administered orally once and observed for side effects or lethality for 10 days after administration. That is, on the day of dosing, changes in general symptoms and the presence or absence of dead animals were observed at least once in the morning, at least once every afternoon from 1 hour, 4 hours, 8 hours, 12 hours after the administration and from the next day until the 10th. In addition, the animals were killed and dissected at 10 days of administration, and the internal organs were visually examined. Changes in body weight were measured at daily intervals from the day of administration, and the weight loss of the animals by the citrus peel extract was observed.

본 실험은 감귤 과피 추출물에 대하여 경구경로에서의 급성독성의 정도를 파악함으로써 일반약리 및 약효시험에서의 가용 약용량에 대한 정보를 제공하고 독성에 대한 기초 자료를 도출함을 목적으로 실시하여 아래와 같은 결과를 얻었다.The purpose of this experiment was to provide information on available doses in general pharmacology and drug efficacy tests and to derive basic data on toxicity by identifying the degree of acute toxicity in the oral route of citrus peel extracts. The result was obtained.

급성 경구독성의 경우는 감귤 과피 추출물 1,000 mg/kg의 용량에서 10일동안 치사동물이 관찰되지 않았다. 10일 후 생존동물에 대한 부검을 실시한 바, 특별한 병변 육안 소견이 없었으며, 투여 익일부터 10일간 어떠한 체중의 감소 없이 정상적인 체중의 증가가 관찰되었다.In the case of acute oral toxicity, no lethal animals were observed for 10 days at the dose of 1000 mg / kg citrus peel extract. An autopsy of the surviving animals was performed 10 days later, and there were no gross lesions, and normal body weight gain was observed without any weight loss for 10 days from the day after the administration.

결론적으로 감귤 과피 추출물은 상기의 농도로 경구투여시 독성이 관찰되지 않았다.In conclusion, the citrus peel extract was not toxic upon oral administration.

실시예 4: 실험동물의 식이 조성과 감귤 과피 추출물의 동물 투여 실험Example 4 Dietary Composition of Experimental Animals and Animal Administration of Citrus Peel Extracts

3주령의 스프라그 다우리(Sprague Dawley) 흰쥐 20마리를 충북 음성군의 대한실험 동물센터로부터 구입하여 1주일간 제일제당 실험동물 사료로 사육하고, 4주령(체중: 90∼110g)이 되었을 때, 난괴법(randomized block design)에 의해 2개의 그룹으로 나누었다. 두 그룹의 쥐들에게 각각 두 가지의 서로 다른 고콜레스테롤 식이, 즉, 정상식이(AIN-76 실험동물 식이)에 1% 콜레스테롤(대조군)이 함유된 식이와 1% 콜레스테롤 및 5% 감귤 과피 추출물(실시예 2의 (1)에서 얻은 것)이 함유된 식이를 각각 섭취시켰다. 두 그룹의 쥐들에게 섭취시킨 식이의 조성(%)은 표 3에 나타나 있다.20 Sprague Dawley rats, 3 weeks old, were purchased from the Korean Experimental Animal Center in Eumseong-gun, Chungbuk, Korea, and were bred for one week with experimental animal feed and fertilized at 4 weeks of age (weight: 90-110 g). It was divided into two groups by randomized block design. Two groups of rats each had two different high-cholesterol diets, one containing 1% cholesterol (control) in the normal diet (AIN-76 experimental animal diet) and one percent cholesterol and 5% citrus peel The diet containing each obtained in Example 1 (1) was consumed. The composition of the diets ingested in both groups of rats is shown in Table 3.

식이군성분Dietary group 대조군Control 감귤 과피 추출물 투여군Citrus peel extract group 카제인Casein 2020 2020 D,L-메티오닌D, L-methionine 0.30.3 0.30.3 옥수수 전분Corn starch 1515 1515 슈크로즈Sucrose 4949 4949 셀룰로즈 분말Cellulose powder 55 00 미네랄 혼합물Mineral mixtures 3.53.5 3.53.5 비타민 혼합물Vitamin mixtures 1One 1One 시트르산 콜린Choline Citrate 0.20.2 0.20.2 옥수수유Corn oil 55 55 콜레스테롤cholesterol 1One 1One 감귤 과피 추출물Citrus Peel Extract -- 55 gun 100100 100100

모든 식이들은 고콜레스테롤 식이(1%, wt/wt)에 해당하고, 실험용 흰쥐의 실험실 식이인 AIN-76 식이 조성 중 셀룰로즈, 미네랄 혼합물 및 비타민 혼합물 성분은 미국의 테크라드 프리미어사(TEKLAD premier, Madison, Wisconsin)로부터 구입하였다.All diets correspond to the high cholesterol diet (1%, wt / wt), and the cellulose, mineral and vitamin mixtures in the AIN-76 diet, the laboratory rat's laboratory diet, were obtained from the US-based TEKLAD premier, Madison. , Wisconsin).

두 식이군의 쥐들에게 6주동안 해당 식이를 물과 함께 자유로이 섭취하도록 하였으며, 식이섭취량을 매일 기록하고 7일마다 체중을 측정하였다. 동물사육이 종료된 후 사육일지의 자료를 분석한 결과, 식이 섭취량과 체중증가에 있어서는 2개군간 유의적인 차이가 없었으며 정상적인 성장을 보였다.Rats of both diets were allowed to eat the diet freely with water for 6 weeks, and their dietary intake was recorded daily and weighed every 7 days. After the animal breeding was completed, the data on the breeding journals were analyzed, and there was no significant difference between the two groups in terms of dietary intake and weight gain.

실시예 5: 실험동물의 혈중 총콜레스테롤, HDL-콜레스테롤 및 중성 지질 함량 측정Example 5 Determination of Total Cholesterol, HDL-Cholesterol and Neutral Lipid Contents in Experimental Animals

실험 식이의 투여가 흰쥐의 혈중 콜레스테롤 및 중성지질 함량에 미치는 영향을 다음과 같이 조사하였다.The effects of experimental diet on blood cholesterol and triglyceride content in rats were investigated as follows.

두 식이군의 쥐들로부터 혈액 시료를 채취하고, 이로부터 덱스트란-설페이트를 포함한 HDL-콜레스테롤 시약(Sigma Chemical Co. Cat. No. 352-3)을 이용하여 혈장 H6DL 분획을 분리하였다. 총 콜레스테롤과 HDL-콜레스테롤 농도는 시그마사의 총 콜레스테롤 키트(Cat. No. 352-100)를 사용한 효소발색법(Allain et al.,Clin. Chem., 20, 470-475(1974))에 의해 측정하였다. 중성 지질 농도는 시그마 진단 키트(Cat. No. 339-50)를 사용하여 측정하였다(Bucolo, G. and David, H.,Clin. Chem., 19, 476-482(1973)). 그 결과, 혈장 총 콜레스테롤 농도는 감귤 과피 추출물 투여군이 대조군에 비해 20% 감소하였으나 HDL이나 중성지방 농도에는 큰 변화가 없었다.Blood samples were taken from the rats of both diets, from which plasma H6DL fractions were separated using HDL-cholesterol reagent (Sigma Chemical Co. Cat. No. 352-3) including dextran-sulfate. Total cholesterol and HDL-cholesterol concentrations were measured by enzymatic coloration using Sigma's Total Cholesterol Kit (Cat. No. 352-100) (Allain et al., Clin. Chem., 20 , 470-475 (1974)). It was. Neutral lipid concentrations were measured using Sigma Diagnostic Kit (Cat. No. 339-50) (Bucolo, G. and David, H., Clin. Chem., 19 , 476-482 (1973)). As a result, the plasma total cholesterol concentration was 20% decreased in the citrus peel extract group compared with the control group, but there was no significant change in the HDL or triglyceride concentration.

실시예 6: 감귤 과피 추출물을 이용한 건강개선용 기능성 음료 제조Example 6 Preparation of Functional Drink for Health Improvement Using Citrus Peel Extract

상기 실시예 2의 (1)에서 제조된 감귤 과피 추출물을 포함하는 건강개선용 기능성 음료들을 다음과 같이 제조하였다.Functional beverages for improving health comprising the tangerine peel extract prepared in Example (1) of Example 2 were prepared as follows.

(1) 야채쥬스 제조(1) vegetable juice production

헤스페리딘 또는 나린진 200㎎ 내지 10000㎎, 또는 감귤 과피 추출물 10 내지 100g을 각종 야채즙 1000㎖에 가하여 기능성 야채쥬스를 제조하였다.Hesperidin or naringin 200 mg to 10000 mg, or 10-100 g of citrus peel extract were added to 1000 ml of various vegetable juices to prepare functional vegetable juices.

(2) 과일쥬스 제조(2) fruit juice production

헤스페리딘 또는 나린진 200㎎ 내지 10000㎎, 감귤 과피 추출물 10 내지 100g을 포도, 파인애플, 사과 또는 바나나 과일쥬스 1000㎖에 가하여 기능성 과일쥬스를 제조하였다.Hesperidin or naringin 200 mg to 10000 mg, citrus peel extract 10 to 100 g was added to 1000 ml of grape, pineapple, apple or banana fruit juice to prepare a functional fruit juice.

(3) 탄산음료 제조(3) carbonated beverage manufacturing

헤스페리딘 또는 나린진 200㎎ 내지 10000㎎, 감귤 과피 추출물 1 내지 100g을 코카콜라 또는 펩시콜라 1000㎖에 가하여 기능성 탄산음료를 제조하였다.200 mg to 10000 mg of hesperidin or naringin and 1 to 100 g of citrus peel extract were added to 1000 ml of Coca Cola or Pepsi Cola to prepare a functional carbonated beverage.

헤스페리딘 또는 나린진을 포함하는 감귤류의 과피 추출물을 각종 음료에 첨가함으로써 제조된 건강개선용 기능성 음료는 항산화, 혈압강하, 혈중 콜레스테롤 강하, 항암 작용 등의 효과를 나타낼 수 있다.The functional beverage for health improvement prepared by adding the extract of citrus peel containing hesperidin or naringin to various beverages may exhibit effects such as antioxidant activity, lowering blood pressure, lowering blood cholesterol, and anticancer action.

Claims (3)

음료 1000ml에 대하여 헤스페리딘 200 내지 10000mg, 나린진 200 내지 10000mg 또는 감귤류의 과피 추출물 10 내지 100g을 첨가하여 제조된 건강개선용 기능성 음료.A functional beverage for health improvement prepared by adding 200-10000 mg of hesperidin, 200-10000 mg of naringin, or 10-100 g of citrus rind extract with respect to 1000 ml of beverage. 제 1 항에 있어서,The method of claim 1, 상기 감귤류가 하귤, 당유자, 오렌지, 레몬, 감귤, 자몽 또는 유자인 기능성 음료.The citrus fruit is a functional drink of mandarin orange, sugar, orange, lemon, citrus, grapefruit or citron. 제 1 항에 있어서,The method of claim 1, 상기 음료가 야채쥬스, 과일쥬스 또는 탄산음료인 것을 특징으로 하는 건강개선용 기능성 음료.Functional drink for health improvement, characterized in that the beverage is vegetable juice, fruit juice or carbonated beverage.
KR1019980013283A 1997-10-28 1998-04-14 Functional drink containing health extract of citrus peel KR19990080214A (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
KR1019980013283A KR19990080214A (en) 1998-04-14 1998-04-14 Functional drink containing health extract of citrus peel
CA002307890A CA2307890A1 (en) 1997-10-28 1998-10-20 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
CA002307891A CA2307891A1 (en) 1997-10-28 1998-10-20 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
EP98951777A EP1063988A1 (en) 1997-10-28 1998-10-20 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor ofmacrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
EP98951775A EP1024819A1 (en) 1997-10-28 1998-10-20 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
EP98951776A EP1032381B1 (en) 1997-10-28 1998-10-20 Naringin and naringenin as preventive or treating agent for hepatic diseases
CN98810715A CN1278182A (en) 1997-10-28 1998-10-20 Citrus peel extract as inhibitor of acyl CoA-cholesterol-0-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall
CN98810701A CN1124133C (en) 1997-10-28 1998-10-20 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent
PCT/KR1998/000324 WO1999021549A1 (en) 1997-10-28 1998-10-20 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
JP2000517728A JP3333777B2 (en) 1997-10-28 1998-10-20 Acyl COA-cholesterol-O-acyl transferase inhibitor, inhibitor of macrophage-lipid complex accumulation on arterial wall, and citrus peel extract as prophylactic or therapeutic agent for liver disease
DE69817862T DE69817862T2 (en) 1997-10-28 1998-10-20 NARINGIN AND NARINGENIN AS A MEDICINE FOR PREVENTING OR TREATING LIVER DISEASES
PCT/KR1998/000322 WO1999021570A1 (en) 1997-10-28 1998-10-20 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
CN98810708A CN1124134C (en) 1997-10-28 1998-10-20 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent
JP2000517706A JP2001520992A (en) 1997-10-28 1998-10-20 Acyl COA-cholesterol-O-acyl transferase inhibitor, inhibitor of macrophage-lipid complex accumulation on arterial wall, and naringin and naringenin as liver disease preventive or therapeutic agent
CA002307553A CA2307553C (en) 1997-10-28 1998-10-20 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
PCT/KR1998/000323 WO1999021548A1 (en) 1997-10-28 1998-10-20 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
JP2000517707A JP2001520993A (en) 1997-10-28 1998-10-20 Acyl COA-cholesterol-O-acyltransferase inhibitors, inhibitors of macrophage-lipid complex accumulation on arterial walls and hesperidin and hesperetin as agents for preventing or treating liver diseases
US09/181,393 US6165984A (en) 1997-10-28 1998-10-28 Naringin and naringenin as inhibitors of acyl CoA-cholesterol-o-acyltransferase
US09/751,101 US20010002264A1 (en) 1997-10-28 2000-12-28 Citrus peel extract as inhibitor of fatty streak formation on the arterial wall
US09/728,917 US20010014357A1 (en) 1997-10-28 2001-02-12 Citrus peel extract as inhibitor of ACYL coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019980013283A KR19990080214A (en) 1998-04-14 1998-04-14 Functional drink containing health extract of citrus peel

Publications (1)

Publication Number Publication Date
KR19990080214A true KR19990080214A (en) 1999-11-05

Family

ID=65890298

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980013283A KR19990080214A (en) 1997-10-28 1998-04-14 Functional drink containing health extract of citrus peel

Country Status (1)

Country Link
KR (1) KR19990080214A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010077721A (en) * 2000-02-08 2001-08-20 주용준 A producing method of enriched juice with orange peel
KR100386704B1 (en) * 2000-10-06 2003-06-02 우강융 A citron juice and process for preparation thereof
KR20030042597A (en) * 2001-11-23 2003-06-02 정인한 A functional health-drink and its drinking methode
KR20040079347A (en) * 2004-07-23 2004-09-14 김연일 Health drink using pomelo

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010077721A (en) * 2000-02-08 2001-08-20 주용준 A producing method of enriched juice with orange peel
KR100386704B1 (en) * 2000-10-06 2003-06-02 우강융 A citron juice and process for preparation thereof
KR20030042597A (en) * 2001-11-23 2003-06-02 정인한 A functional health-drink and its drinking methode
KR20040079347A (en) * 2004-07-23 2004-09-14 김연일 Health drink using pomelo

Similar Documents

Publication Publication Date Title
Peterson et al. Flavonoids: dietary occurrence and biochemical activity
Yamakoshi et al. Safety evaluation of proanthocyanidin-rich extract from grape seeds
González-Molina et al. Natural bioactive compounds of Citrus limon for food and health
Espín et al. Nutraceuticals: facts and fiction
Uyoh et al. Evaluation of the chemical composition of Tetrapleura tetraptera (Schum and Thonn.) Taub. accessions from Cross River State, Nigeria.
Asuk et al. The biomedical significance of the phytochemical, proximate and mineral compositions of the leaf, stem bark and root of Jatropha curcas
KR100428936B1 (en) Health improving Spice Composition
KR20000019717A (en) Composition comprising rutin and quercetin for preventing and treating hyperlipidemia, arteriosclerosis and liver disease
Hamad et al. Detoxification of aflatoxin B1 and ochratoxin A using Salvia farinacea and Azadirachta indica water extract and application in meat products
Alimi et al. An in vitro evaluation of the antioxidant and antidiabetic potential of Sutherlandia montana E. Phillips & RA Dyer leaf extracts
KR100304430B1 (en) Health-improving food composition comprising ginseng and citrus peel derivative
KR19990079683A (en) Functional health food containing citrus rind powder or rind extract
KR20210048467A (en) Method for preparing Citrus peel extract containing increased content of flavonoid
KR19990080214A (en) Functional drink containing health extract of citrus peel
KR100314477B1 (en) Composition for improving lipid metabolism and decreasing bllod pressure which comprises jujube and citrus peel extracts
Andlauer et al. Chemoprevention-a novel approach in dietetics
KR19990080215A (en) High Functional Citrus Juice
KR100258584B1 (en) Acyl coa: cholesterol-o-acyltransferase inhibitory composition comprising citrus peel extract
KR100296250B1 (en) Composition for improving lipid metabolism and lowering blood pressure containing jujube extract and tangerine pericarp extract
KR19990080216A (en) Tangerine tea with improved functionality
KR100254908B1 (en) 3-hydroxy-3-methylglutaryl coa reductase inhibitory composition comprising vitamin c and citrus peel extract
Ram et al. Medicinal importance of citrus products and by-products-a review
Islam et al. Biological Investigation of Jatropha gossypiifolia: A Stiff Medicinal Plant in Bangladesh: Biological Investigation of Jatropha gossypiifolia
Miller et al. Potential health benefits of blackcurrants
Ekpo et al. Determination of Proximate Composition and Phytochemical Constituents of Corchorus oliterious (Ewudu) Harvested in Ugep, Cross River State

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application